Triple

T32400506
Position Surface form Disambiguated ID Type / Status
Subject YOSEMITE E827934 entity
Predicate evaluatesIndication P30846 FINISHED
Object diabetic macular edema LITERAL FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: diabetic macular edema | Statement: [YOSEMITE, evaluatesIndication, diabetic macular edema]
PD Predicate disambiguation gpt-5-mini-2025-08-07
Target predicate: evaluatesIndication
Context triple: [YOSEMITE, evaluatesIndication, diabetic macular edema]
  • A. hasIndication
    Indicates that one entity (typically a product, treatment, or intervention) is intended, approved, or suitable for use in addressing, preventing, or managing a particular condition, purpose, or circumstance.
  • B. indicatedFor
    Indicates...that one entity (typically a treatment, procedure, or product) is recommended or appropriate for use in relation to another entity (such as a condition, symptom, or patient group).
  • C. supportsEvaluation chosen
    Indicates that one entity provides the necessary functionality, resources, or conditions for another entity to be assessed, tested, or evaluated.
  • D. canIndicate
    Indicates that one entity has the potential or capacity to serve as a sign, signal, or evidence of another entity or condition.
  • E. treatmentIndication
    Indicates that a treatment is intended to address, alleviate, or prevent a particular condition, symptom, or medical indication.
  • F. None of above.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f34919342c8190a4c3bf35a90d4e58 completed April 30, 2026, 12:20 p.m.
NER Named-entity recognition batch_69f6c8159edc8190b1c87015e0c820e8 completed May 3, 2026, 3:59 a.m.
PD Predicate disambiguation batch_69f6c3f42fbc8190a06eb1044c9e6094 completed May 3, 2026, 3:41 a.m.
Created at: May 1, 2026, 12:52 a.m.